Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Active Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

NCT00982007 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT00982007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00982007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Active Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
August 31, 2011
Enrollment
997 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia